Mark C. Ensign

Mark C. Ensign is the Chief Operating Operator and Chief Scientific Officer having over 25 years of business experience. Mr. Ensign is a multi-disciplinary scientist and holds several degrees. He oversees the research operations including the strategic direction of Cristcot’s drug pipeline, and provides this guidance to the CEO and Board of Directors. Mr. Ensign is intimately familiar with all aspects of product development within the organization and the evaluation/selection of business partners including; formulation development, laboratories, toxicological studies, clinical research organizations, API and excipient suppliers, medical and regulatory consultants, and manufacturing.